Synthetic Blood Substitutes And Blood Products: Global Market Poised For Rapid Growth by 2025

The Business Research Company's Synthetic Blood Substitutes And Blood Products: Global Market Poised For Rapid Growth by 2025

LONDON, GREATER LONDON, UNITED KINGDOM, March 28, 2025 /EINPresswire.com/ -- Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What's behind the rapid growth of the synthetic blood substitutes and blood products market size in recent years?

The synthetic blood substitutes and blood products market size has grown rapidly in recent years. It will grow from $6.55 billion in 2024 to $7.62 billion in 2025 at a compound annual growth rate CAGR of 16.3%. This historic period growth can be attributed to an aging population, increasing demand for blood transfusions, rising demand for safe and contaminant-free blood, growing awareness of blood transfusion risks, and an increased focus on emergency medical care.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=21294&type=smp

Where is the synthetic blood substitutes and blood products market headed?

The synthetic blood substitutes and blood products market size is expected to see rapid growth in the next few years. It will grow to $13.76 billion in 2029 at a compound annual growth rate CAGR of 15.9%. This forecast period growth can be attributed to the expanding application in military and disaster response, increasing awareness of alternative blood substitutes, growing prevalence of blood-related disorders, and a rising incidence of trauma and emergency surgeries. Major trends in the forecast period include the development of hemoglobin-based oxygen carriers, regulatory approvals and research, advancements in biotechnology, regenerative medicine advancements, and integration of artificial intelligence AI.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/synthetic-blood-substitutes-and-blood-products-global-market-report

What are the key drivers of the synthetic blood substitutes and blood products market?
The rising prevalence of chronic diseases is expected to propel the growth of the synthetic blood substitutes and blood products market going forward. Chronic diseases, long-lasting conditions requiring ongoing medical attention, are attributed to factors including an aging population, unhealthy lifestyles, and increased life expectancy. Synthetic blood substitutes and blood products can play a critical role in managing chronic diseases by addressing specific challenges related to blood loss, anemia, and organ function, common in patients with chronic conditions. For instance, in June 2024, the Australian Institute of Health and Welfare reported an increase in deaths due to chronic conditions in Australia, driving the growth of this market.

Who are the key players in the synthetic blood substitutes and blood products market?

Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., and Somatogen Inc.

What are the emerging trends in the synthetic blood substitutes and blood products market?

Major companies in the market are focusing on developing innovative products, like lab-grown blood vessels, enhancing emergency medical care, improving trauma treatment outcomes, and addressing the global shortage of donor blood and tissues. In December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology platform company, received FDA approval for Symvess, an off-the-shelf, bioengineered blood vessel implant for trauma patients, providing a safer alternative to vein harvesting or synthetic grafts.

How is the synthetic blood substitutes and blood products market segmented?

Type: Perfluorocarbon Based Product PFC, Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
End-User: Hospitals And Clinics, Blood Banks, Other End users
Perfluorocarbon Based Product PFC: Emulsion-Based Products, Non-Emulsion-Based Products
Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
Blood Expander: Colloid Solutions, Crystalloid Solutions

What does the regional outlook look like for the synthetic blood substitutes and blood products market?

North America was the largest region in the synthetic blood substitutes and blood products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse More Similar Reports By The Business Research Company:
Anemia And Other Blood Disorder Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report
Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Stem Cell/Cord Blood Banking Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Contact us:
https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn